(Q42952825)

11 November 2017

title

Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma (English)

1 reference

11 November 2017

1 reference

5

1 reference

11 November 2017

Raphaël Maréchal

1

1 reference

11 November 2017

John R Mackey

2

1 reference

11 November 2017

Raymond Lai

3

1 reference

11 November 2017

Pieter Demetter

4

1 reference

11 November 2017

Marc Polus

6

1 reference

11 November 2017

Carol E Cass

7

1 reference

11 November 2017

Isabelle Salmon

8

1 reference

11 November 2017

Jacques Devière

9

1 reference

11 November 2017

Jean-Luc Van Laethem

10

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

11 November 2017

1 reference

11 November 2017

volume

116

1 reference

11 November 2017

issue

22

1 reference

11 November 2017

page(s)

5200-5206

1 reference

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

The intracellular localization of deoxycytidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Mammalian deoxyribonucleoside kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors. III. dCOP-diacylglycerol formation in tonsillar lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

inferred from DOI database lookup

7 January 2021

based on heuristic

Maximizing therapeutic gain with gemcitabine and fractionated radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

inferred from DOI database lookup

7 January 2021

based on heuristic

Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25303

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.25303

1 reference

11 November 2017

1 reference